LONDON STOCK EXCHANGE · GSK
-0.04% · -$0.0200 · Vol Not reported
Pre-market · updated 05:40:55 ET
GSK plc

GSK plc

Pharmaceuticals
$50.26
Card
Relationship Map

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D
Score not reportedVeridion does not publish a score-history trend for GSK until the ticker has a real scored snapshot. No trend is implied for this page.Review methodology
AI Analysis
Sovereign

Why is GSK moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading GSK catalysts
About GSK plc
Pharmaceuticals
Listed since
1976
Employees
67K
Country
GB

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$50.28
Last session
Day high
$50.28
Last session
Day low
$50.28
Last session
Previous close
$50.28
52W high
$61.18
-17.85% from high
52W low
$38.96
51% of range
Market cap
$99.2B
P/E
15.53×
EPS
$1.18
Beta
0.01
Shares out
2B
Avg volume
4.1M
VWAP
$50.28
Last session
Price history computed in-house
1W
-1.26%
1M
-2.90%
3M
-1.02%
1Y
+28.64%
YTD
+2.49%
SMA 50 $51.79 · below
SMA 200 $52.00 · below
52W position 51%

GSK overview

Loading financial statements
Loading GSK Form 4 filings
Public disclosures

Congress activity in GSK

Federal contracts

GSK contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for GSK in this window.
Lobbying spend

GSK lobbying filings, year to date.

Registered lobbying filings matched to GSK plc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for GSK in this window.
Loading news for GSK
Analyst ratings
Sovereign unlock shows live analyst consensus for GSK.
Options
Sovereign unlock shows live options positioning for GSK.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.